Filter by
Selections
December 21, 2023
Arrowhead Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Read MoreNovember 28, 2023
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-DM1 for Type 1 Myotonic Dystrophy
Read MoreNovember 21, 2023
Arrowhead Pharmaceuticals to Participate in Piper Sandler 35th Annual Healthcare Conference
Read MoreNovember 13, 2023
Arrowhead Presents New Phase 2 Data on Plozasiran and Zodasiran at AHA 2023
Read MoreNovember 6, 2023
Arrowhead Pharmaceuticals to Participate in Jefferies London Healthcare Conference
Read MoreNovember 2, 2023
Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023
Read MoreOctober 31, 2023